Related Experiment Videos
[Conjugated vaccines]
1Unité d'Epidémiologie pédiatrique et Vaccination, Ecole de Santé publique, U.L.B.
Insights
Conjugate vaccines enhance protection for young children against serious infections like Haemophilus influenzae type b, meningococcal C, and pneumococcal disease by converting T-independent antigens into T-dependent ones. This review examines their efficacy, focusing on antigen interference, immune response surrogates, herd immunity, and serotype replacement.
Area of Science:
- Immunology
- Vaccinology
- Pediatric Infectious Diseases
Context:
- Conjugate vaccines are crucial for extending disease prevention in children under two years old.
- They convert T-independent antigens into T-dependent ones, enabling robust immune responses.
- This strategy protects against severe infections like Haemophilus influenzae type b, meningococcal C, and pneumococcal disease.
Purpose:
- To review the efficacy and immunological responses of three key conjugate vaccines.
- To address critical questions regarding antigen interference, serological correlates of protection, herd immunity, and serotype replacement.
Summary:
- Conjugate vaccines link capsular polysaccharides to carrier proteins, enhancing immunogenicity in infants.
- This review synthesizes data on Haemophilus influenzae type b, meningococcal C, and pneumococcal conjugate vaccines.
- Key areas explored include immune interference, surrogate markers for protection, community-level effects (herd immunity), and shifts in circulating pathogen strains.
Impact:
- Provides a comprehensive overview of conjugate vaccine performance and immunological considerations.
- Informs public health strategies for childhood immunization programs.
- Highlights areas for future research in vaccine development and implementation.
Abstract:
Conjugate vaccines extend the vaccinal prevention for children to more diseases. Conjugating the capsular polysaccharide to a carrier protein transforms a T-independent antigen in a T-dependent, allowing protection of the children (before 2 years of age) against Haemophilus influenzae type b, meningococcal C and pneumococcal infections. This article reviews the 3 conjugate vaccines and their results with focus on some questions: antigens interference in the immunological response, serological subrogate for protection, herd immunity and replacement of circulating serotypes.